Orchid Pharma
Held by 14 funds across 5 fund houses in our coverage.
Coverage: 25 of India's largest fund houses — growing.
Orchid Pharma: fund ownership at a glance
14 schemes from 5 fund houses in our coverage hold Orchid Pharma, worth ₹763 Cr in total as of their latest monthly disclosures.
13 of them are actively managed. The largest active position is in Kotak Special Opportunities Fund (Kotak MF), at 2.72% of its portfolio, followed by Kotak Healthcare Fund (1.64%) and Kotak Consumption Fund (1.60%). The other 1 are index funds and ETFs, which hold it because their index does; they account for 0% of the value held.
By value, Small Cap schemes hold the most (₹386 Cr), and Quant MF holds the most of any fund house (₹337 Cr).
Own several funds? The fund overlap tool shows how much of Orchid Pharma and the rest of their portfolios they share.
Who holds Orchid Pharma?
Orchid Pharma holdings — FAQ
- How many mutual funds hold Orchid Pharma?
- 14 mutual funds and ETFs in WhoHolds' coverage hold Orchid Pharma, spread across 5 fund houses.
- Which fund holds the most Orchid Pharma?
- Kotak Special Opportunities Fund (Kotak MF) gives it the highest weight, at 2.72% of the fund's portfolio.
- What is the total value of Orchid Pharma held by these funds?
- Together these funds hold about ₹763 Cr worth of Orchid Pharma (ISIN-verified equity positions).
- As of when is this Orchid Pharma holdings data?
- Portfolios as on Kotak MF Aug 2026 · UTI MF Aug 2026 · Tata MF Aug 2026 · Quant MF Aug 2026 · Motilal Oswal MF Aug 2026, taken from each AMC's public monthly portfolio disclosure. This is information only, not investment advice.
Portfolios as on: Kotak MF Aug 2026 · UTI MF Aug 2026 · Tata MF Aug 2026 · Quant MF Aug 2026 · Motilal Oswal MF Aug 2026. ISIN-verified equity positions from public AMC disclosures. Not investment advice.
Weight = the position as a % of that fund's portfolio. MoM = change vs the previous month's disclosure. Values in ₹: L = Lakh (1,00,000), Cr = Crore (1,00,00,000).